The long-term clinical results of a platelet glycoprotein IIb/IIIa receptor blocker (Abciximab: Reopro) coated stent in patients with coronary artery disease.

MLA

Kim, Weon, et al. “The Long-Term Clinical Results of a Platelet Glycoprotein IIb/IIIa Receptor Blocker (Abciximab: Reopro) Coated Stent in Patients with Coronary Artery Disease.” The Korean Journal of Internal Medicine, vol. 19, no. 4, Dec. 2004, pp. 220–29. EBSCOhost, https://doi.org/10.3904/kjim.2004.19.4.220.

APA

Kim, W., Jeong, M. H., Hong, Y. J., Lee, S. H., Park, W. S., Kim, J. H., Kim, I. S., Choi, M. J., Ahn, Y. K., Cho, J. G., Park, J. C., Cho, D. L., Kim, H., & Kang, J. C. (2004). The long-term clinical results of a platelet glycoprotein IIb/IIIa receptor blocker (Abciximab: Reopro) coated stent in patients with coronary artery disease. The Korean Journal of Internal Medicine, 19(4), 220–229. https://doi.org/10.3904/kjim.2004.19.4.220

Chicago

Kim, Weon, Myung Ho Jeong, Young Joon Hong, Seng Hyun Lee, Woo Seok Park, Ju Han Kim, In Soo Kim, et al. 2004. “The Long-Term Clinical Results of a Platelet Glycoprotein IIb/IIIa Receptor Blocker (Abciximab: Reopro) Coated Stent in Patients with Coronary Artery Disease.” The Korean Journal of Internal Medicine 19 (4): 220–29. doi:10.3904/kjim.2004.19.4.220.